Live Breaking News & Updates on Sutro biopharma inc

Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRa-targeted ADC, on January 4, 2024

Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRa-targeted ADC, on January 4, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sutro-biopharma , Luveltamab-tazevibulin , Emily-white , Drug-administration , Exchange-commission , Sutro-biopharma-inc , Fast-track , Ovarian-cancer , Rare-pediatric-disease , South-san , Private-securities-litigation-reform-act ,

Sutro Biopharma to Host Investor Webcast Highlighting

SOUTH SAN FRANCISCO, Calif., Dec. 14, 2023 (GLOBE NEWSWIRE) Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology.

Sutro-biopharma , Luveltamab-tazevibulin , Emily-white , Drug-administration , Sutro-biopharma-inc , Exchange-commission , Fast-track , Ovarian-cancer , Rare-pediatric-disease , South-san , Private-securities-litigation-reform-act , Nasdaq-stro

Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (luvelta) in Pediatric Patients with Relapsed/Refractory CBF/GLIS Presented at ASH 2023

– Complete remission seen in 42% of patients with CBF/GLIS AML with ≥5% blasts and 75% of pediatric patients with CBF/GLIS AML with .

United-states , San-diego , California , South-san-francisco , American , Luveltamab-tazevibulin , Soheil-meshinchi , Sutro-biopharma , Emily-white , Globenewswire-inc , Exchange-commission , American-society-of-hematology-annual-meeting

VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in

VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United-states , Janet-graesser , Jim-wassil , Jennifer-zibuda , Jakub-simon , Nasdaq , Groupa-strep , Sutro-biopharma-inc , Free-platform-technology , Exchange-commission , Vaxcyte-inc , Corporate-communications

VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte's 24-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte's 24-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Jakub-simon , Jim-wassil , Janet-graesser , Jennifer-zibuda , Sutro-biopharma-inc , Free-platform-technology , Groupa-strep , Corporate-communications , Exchange-commission , Vaxcyte-inc , Nasdaq

Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit

Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Contactemily-whitesutro-biopharma , Sutro-biopharma , Sutro-biopharma-inc , Bill-newell , Chief-executive-officer , Oncology-summit , Investor-relations , South-san , Emily-whitesutro-biopharma ,

Vaxcyte Appoints Jacks Lee to Board of Directors

SAN CARLOS, Calif., Nov. 28, 2023 Vaxcyte, Inc. , a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today.

Jennifer-zibuda , Janet-graesser , Groupa-strep , Corporate-communications , University-of-central-missouri , Vaxcyte-inc , Exchange-commission , Merck-co-inc , Sutro-biopharma-inc , Nasdaq , University-of-wisconsin , Therapeutics-inc

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates

Vaxcyte Obtains Exclusive Rights to Independently Develop and Manufacture Cell-Free Extract, a Key Component of the Company’s Pneumococcal Conjugate Vaccine Franchise Manufacturing Rights.

Jennifer-zibuda , Sutro-biopharma , Emily-white , Janet-graesser , Exchange-commission , Groupa-strep , Vaxcyte-inc , Corporate-communications , Sutro-biopharma-inc , Obtains-exclusive-rights , Independently-develop , Manufacture-cell-free-extract

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $14.00 Average Target Price from Analysts

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year price […]

Brunilda-shtylla , Sutro-biopharma , Piper-sandler , Deutsche-bank , Sectoral-asset-management-inc , Capital-partners , Deutsche-bank-aktiengesellschaft , Nasdaq , Sutro-biopharma-inc , Get-free-report , Bank-aktiengesellschaft , Asset-management

Sutro Biopharma (STRO) Appoints Jane Chung to President and COO

Sutro Biopharma (STRO) Appoints Jane Chung to President and COO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Columbia-university , Jane-chung , Astrazeneca , Genentech , John-university , Sutro-biopharma-inc , Sutro-biopharma , Chief-operating-officer , Bill-newell , Chief-executive